Lipocine Inc. (LPCN) Social Stream
LIPOCINE INC (LPCN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering LIPOCINE INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 3 | $6 | $2.5 | $3.75 | $3.11 | 20.58% |
| 2022-05-10 | 2 | $6 | $2.5 | $3.75 | $3.11 | 20.58% |
| 2022-05-20 | 2 | $5.5 | $2.5 | $3.625 | $3.11 | 16.56% |
| 2022-08-10 | 2 | $5.5 | $2 | $3.375 | $3.11 | 8.52% |
| 2022-11-10 | 2 | $5.5 | $2 | $3.333 | $3.11 | 7.17% |
| 2023-03-13 | 2 | $5.5 | $2 | $3.833 | $3.11 | 23.25% |
| 2023-03-16 | 2 | $85.034 | $34.013 | $62.358 | $3.11 | 1905.08% |
| 2023-05-17 | 2 | $85.034 | $33 | $51.344 | $3.11 | 1550.93% |
| 2023-08-16 | 2 | $40 | $33 | $36.333 | $3.11 | 1068.26% |
| 2023-11-09 | 1 | $40 | $33 | $36.5 | $3.11 | 1073.63% |
The Trend in the Analyst Price Target
LPCN's average price target has moved up $33.12 over the prior 15 months.
Over the past 34 weeks, LPCN's average upside potential has been 2,185.78%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-16 | 2 | 85.034 | 34.013 | 62.358 | 0.338 | 18349.11% |
| 2023-07-11 | 2 | 40.000 | 33.000 | 36.333 | 4.390 | 727.63% |
| 2023-08-16 | 1 | 40.000 | 33.000 | 36.333 | 4.990 | 628.12% |
| 2023-08-16 | 2 | 40.000 | 36.000 | 38.000 | 4.990 | 661.52% |
| 2023-08-16 | 2 | 40.000 | 33.000 | 36.333 | 4.990 | 628.12% |
LPCN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
LPCN's average broker recommendation rating improved by 0 over the prior 40 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LPCN as an investment opportunity.
- LPCN has a greater number of analysts covering the stock than 32.73% of all US stocks.
- In terms of how LIPOCINE INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 471.47% of that group.
- LPCN has a greater upside potential (average analyst target price relative to current price) than 632.3% of stocks in the small market cap category.
- In the context of stocks in the small market cap category, LIPOCINE INC's variance in analysts' estimates is lower than -702.56% of them.
Stocks similar to LIPOCINE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VSTM, RGLS, and KPTI.
View All Top Stocks by Price Target
Is LPCN a Buy, Hold or Sell? See the POWR Ratings now!